Updated: Jun 28, 2026

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
Published on: September 22, 2011
James M Abdullah1, Andrzej Joachimiak, Frank R Collart
1Biosciences Division, Argonne National Laboratory, Lemont, IL, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
This study introduces an efficient, high-throughput cloning and expression strategy using 48- and 96-well plates for generating validated expression clones in Escherichia coli, reducing time and material needs.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: